RS

Ramanujam Sudarsanam

Director Director DIN 05338713
DIN 05338713 First appointment Aug 2012 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2012
Shareholding value Locked Premium profile

About Ramanujam Sudarsanam

Ramanujam Sudarsanam has 13 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 05338713
Primary Designation Director
First Appointment 13 Aug 2012
Oldest Company Age 13 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Ciims Pharma Private Limited U33120TN2012PTC087189
Director 13 Aug 2012 2012 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ciims Pharma Private Limited
Premium access

Shareholding and investment profile for Ramanujam Sudarsanam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramanujam Sudarsanam

Ramanujam Sudarsanam has 13 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Ramanujam Sudarsanam is associated with 0 companies as Director.

Ramanujam Sudarsanam has expertise in General Business.

Ramanujam Sudarsanam has 13 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available